As of 2025-08-20, the Intrinsic Value of Clinica Baviera SA (CBAV.MC) is 63.45 EUR. This CBAV.MC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 44.90 EUR, the upside of Clinica Baviera SA is 41.30%.
The range of the Intrinsic Value is 47.35 - 99.29 EUR
Based on its market price of 44.90 EUR and our intrinsic valuation, Clinica Baviera SA (CBAV.MC) is undervalued by 41.30%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 47.35 - 99.29 | 63.45 | 41.3% |
| DCF (Growth 10y) | 58.75 - 117.43 | 77.08 | 71.7% |
| DCF (EBITDA 5y) | 50.61 - 61.20 | 56.01 | 24.7% |
| DCF (EBITDA 10y) | 61.91 - 78.43 | 69.93 | 55.8% |
| Fair Value | 86.70 - 86.70 | 86.70 | 93.10% |
| P/E | 43.19 - 71.30 | 50.63 | 12.8% |
| EV/EBITDA | 44.65 - 58.85 | 50.19 | 11.8% |
| EPV | 54.86 - 72.98 | 63.92 | 42.4% |
| DDM - Stable | 30.74 - 85.69 | 58.22 | 29.7% |
| DDM - Multi | 41.23 - 82.40 | 54.27 | 20.9% |
| Market Cap (mil) | 732.32 |
| Beta | 0.46 |
| Outstanding shares (mil) | 16.31 |
| Enterprise Value (mil) | 732.73 |
| Market risk premium | 7.44% |
| Cost of Equity | 7.77% |
| Cost of Debt | 4.25% |
| WACC | 7.37% |